Target intelligence / Profile preview

Antisense transcript to fibrinogen alpha chain

Molecular classification
Long non-coding RNA (lncRNA), Antisense transcript
01

Overview

The "antisense transcript to FGA" is a long non-coding RNA transcribed from the opposite strand of the FGA (Fibrinogen alpha chain) genomic locus. Antisense RNAs are frequently implicated in regulation of their sense counterpart's transcription, often through modulation of chromatin architecture, transcription initiation rates, transcript processing, and RNA stability. While antisense transcription can affect the abundance and dynamics of protein-coding transcripts such as FGA, these RNAs are generally not directly targeted by small molecules or biologics and are not considered conventional therapeutic targets[1][3][5]. The designation "ENSG00000306549" is an Ensembl identifier, and there are no common aliases or target-family assignments for this locus. Currently, there are no drugs or clinical therapeutics designed to specifically modulate this antisense transcript, and its biological or pathological importance in humans beyond regulatory RNA function remains undetermined.

Other names
ENSG00000306549novel transcript antisense to FGAFGA antisense RNA
02

Biological functions

Regulation of gene expression (specifically, modulation of FGA mRNA transcription, processing, and stability)Chromatin remodeling and modification in the vicinity of the FGA gene
03

Disease associations

Other (Potential regulatory relevance in coagulation or fibrinogen-related pathologies is possible but not demonstrated; currently, no direct disease association)

Beyond the preview

Go deeper on Antisense transcript to fibrinogen alpha chain.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antisense transcript to fibrinogen alpha chain.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call